| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/28/2000 | EP1011635A1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 06/28/2000 | EP1011634A1 Preparation of pharmaceutical compositions |
| 06/28/2000 | EP1011608A2 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs |
| 06/28/2000 | EP1011457A1 Stent lining |
| 06/28/2000 | EP1011330A1 Central nervous system axon regeneration |
| 06/28/2000 | EP1011328A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 06/28/2000 | EP1011327A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 06/28/2000 | EP1011320A1 Transplacental delivery of oligonucleotides |
| 06/28/2000 | EP0915710B1 Stable radioiodine conjugates and methods for their synthesis |
| 06/28/2000 | EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/28/2000 | EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy |
| 06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
| 06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
| 06/28/2000 | CN1258215A Serine protease and topical retinoid composition |
| 06/28/2000 | CN1258198A Utilisations of oil bodies |
| 06/28/2000 | CN1258191A Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 06/28/2000 | CN1257931A Ferritin for supplementing iron to human body and its preparing process and application |
| 06/28/2000 | CN1257872A Leptospiral vaccine antigen for preventing leptospirosis |
| 06/28/2000 | CN1257871A Somatostatin polypeptide analog and its application |
| 06/28/2000 | CN1053964C Immunochemical detection of in vivo advanced glycosylation endproducts |
| 06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
| 06/28/2000 | CN1053908C Substd. thiazolo [3,2-a] azepine deriv. |
| 06/28/2000 | CN1053838C Synergism of TNF and IL-4 |
| 06/28/2000 | CN1053837C Micro-molecule glucoprotein biologics and its preparation process |
| 06/27/2000 | USRE36755 DNA encoding tumor necrosis factor-α and -β receptors |
| 06/27/2000 | US6080849 Mutant salmonella species with a genetically engineered msbb gene, expresses altered lipid a, has reduced induction of tumor necrosis factor and increased sensitivity to chelating agents; for agents against solid tumors |
| 06/27/2000 | US6080848 Human brain associated protein |
| 06/27/2000 | US6080845 Monoclonal antibody against utricular epithelium |
| 06/27/2000 | US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants |
| 06/27/2000 | US6080841 Human induced tumor protein |
| 06/27/2000 | US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| 06/27/2000 | US6080756 Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
| 06/27/2000 | US6080753 Stimulating nerve growth with immunophilins |
| 06/27/2000 | US6080738 Heterocyclic amide compounds and medicinal uses thereof |
| 06/27/2000 | US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds |
| 06/27/2000 | US6080728 Inhibiting tumor growth |
| 06/27/2000 | US6080727 Oligonucleotide treatments and compositions for human melanoma |
| 06/27/2000 | US6080723 Human actVA-ORF4-like protein |
| 06/27/2000 | US6080722 Methods for utilizing such polynucleotides or polypeptides as a diagnostic marker for colon cancer and as an agent to determine if colon cancer has metastasized |
| 06/27/2000 | US6080721 Pulmonary delivery of active fragments of parathyroid hormone |
| 06/27/2000 | US6080720 Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3) |
| 06/27/2000 | US6080719 Treatment or prophylaxis of allergies and infections and for inhibiting the binding of interleukin-4 (il-4) to the il-4 receptor |
| 06/27/2000 | US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling |
| 06/27/2000 | US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide |
| 06/27/2000 | US6080588 Administering derivative to subject to inhibit or prevent disease associated with binding of antibodies to dna; treatment of systemic lupus erythematosus and inflammatory glomerulonephritis |
| 06/27/2000 | US6080580 Antiinflammatory/antidiabetic/antiarthritic agents; diagnosis and therapy of inflammation and autoimmune diseases; rheumatoid arthritis, crohn's disease, pancreatitis, multiple sclerosis, atopic dermatitis, hepatitis |
| 06/27/2000 | US6080579 Method for producing human intervertebral disc cells |
| 06/27/2000 | US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia |
| 06/27/2000 | US6080577 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 06/27/2000 | US6080559 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
| 06/27/2000 | US6080558 Polynucleotide encoding human growth regulator protein |
| 06/27/2000 | US6080546 Antisense modulation of MEKK5 expression |
| 06/27/2000 | US6080429 Emulsifying an active agent or an aqueous solution by adding to a solution of polymer/solvent; extracting excess solvent with an aqueous solution to produce microspheres; dehydrating drying in a fluidized bed; high speed; noncracking |
| 06/27/2000 | US6080406 Hematopoietic cytokine receptor |
| 06/27/2000 | US6080403 Protease containing hairball remedy and use thereof |
| 06/27/2000 | US6080402 Immobilization of lipases by entrapment in silica matrices |
| 06/27/2000 | US6080400 Compositions for the prevention and treatment of verotoxin-induced disease |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
| 06/27/2000 | US6079416 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis |
| 06/27/2000 | CA2134083C Prophylactic and therapeutic agents for autoimmune diseases |
| 06/27/2000 | CA2131021C Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
| 06/27/2000 | CA2089553C Multidomain hematopoiesis stimulators |
| 06/27/2000 | CA2076744C Viral agent associated with mystery swine disease |
| 06/27/2000 | CA2030581C Pancreatin preparations |
| 06/23/2000 | CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| 06/22/2000 | WO2000036150A1 Antisense modulation of elk-1 expression |
| 06/22/2000 | WO2000036148A1 Antisense modulation of sentrin expression |
| 06/22/2000 | WO2000036130A1 Foamy virus vectors for expressing foreign genes in mammals and the use thereof |
| 06/22/2000 | WO2000036124A2 Plant cell cycle genes and uses thereof |
| 06/22/2000 | WO2000036118A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 06/22/2000 | WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 06/22/2000 | WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/22/2000 | WO2000036105A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | WO2000036104A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | WO2000036103A1 Cytokine receptor chain |
| 06/22/2000 | WO2000036100A1 Protein kinase targeting protein |
| 06/22/2000 | WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 06/22/2000 | WO2000036097A2 Methods for regulating vascularization using gef containing nek-like kinase (gnk) |
| 06/22/2000 | WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 06/22/2000 | WO2000036091A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 06/22/2000 | WO2000036089A2 Methods of immunosuppression |
| 06/22/2000 | WO2000035954A1 Human g protein coupled receptor |
| 06/22/2000 | WO2000035952A2 Compounds for control of eating, growth and body weight |
| 06/22/2000 | WO2000035950A2 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | WO2000035948A1 Methods and compositions for treating disorders involving excitotoxicity |
| 06/22/2000 | WO2000035945A1 Cyclic peptide antifungal agents having a sugar substituent |
| 06/22/2000 | WO2000035944A1 Cyclic peptide antifungal agents |
| 06/22/2000 | WO2000035943A1 Halovir, an antiviral marine natural product, and derivatives thereof |
| 06/22/2000 | WO2000035942A1 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 06/22/2000 | WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof |
| 06/22/2000 | WO2000035937A1 47 human secreted proteins |
| 06/22/2000 | WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/22/2000 | WO2000035935A1 Antisense modulation of cd44 expression |
| 06/22/2000 | WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals |
| 06/22/2000 | WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 06/22/2000 | WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 06/22/2000 | WO2000035478A1 Treatment of papillomavirus infections |
| 06/22/2000 | WO2000035475A2 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia |
| 06/22/2000 | WO2000035474A1 Neurite derived growth factors for use in the treatment of muscular dystrophy |